SCHEMBL7928906

SCHEMBL7928906

Cc1ccc(C2=CC(=O)CCC2C(=O)O)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
S1PR1 P21453 1/20 0.36
S1PR5 Q9H228 1/20 0.36
SIRT1 Q96EB6 2/20 0.35
KDM4E B2RXH2 3/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 2/20 0.33
ESR2 Q92731 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
RAB9A P51151 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7644165 0.85 SLC6A3 (0.38) ALDH1A1MAPTKMT2ASMN1; SMN2POLB
SCHEMBL7633659 0.81 MEN1 (0.46) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL11624889 0.81 HSD17B10 (0.38) ALDH1A1KDM4EMAPTESR2SMN1; SMN2
SCHEMBL17048600 0.74 MMP2 (0.33) SIRT1MAPTMCL1
SCHEMBL7640072 0.74 CHRM2 (0.47) ALDH1A1MAPTKMT2AHSD17B10CFTR
SCHEMBL7634605 0.73 CHRM2 (0.50) ALDH1A1KDM4EKMT2AMEN1RAB9A
SCHEMBL7642686 0.71 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL11621033 0.69 CHRM2 (0.39) ALDH1A1KDM4EKMT2ASMN1; SMN2NPC1
SCHEMBL7643676 0.67 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL11642020 0.65 SMN1; SMN2 (0.46) ALDH1A1S1PR1S1PR5KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010020112-A1 Process for preparing (hetero) aromatic substituted benzene derivatives TOYA TETSUYA (JP) 2001-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020112-A1 Process for preparing (hetero) aromatic substituted benzene derivatives AHR, CYP3A4, CYP4B1 ALDH1A1 1596/4885S1PR1 4270/4885S1PR5 4254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.